Phase 2 Nonalcoholic Steatohepatitis Clinical Trials
4 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–4 of 4 trials
Recruiting
Phase 2
Thyroid Hormone for Treatment of Nonalcoholic Steatohepatitis in Veterans
Liver FibrosisNonalcoholic Steatohepatitis
VA Office of Research and Development128 enrolled1 locationNCT05526144
Recruiting
Phase 2
Study of ADI-PEG 20 Versus Placebo in Subjects With NASH
Nonalcoholic Steatohepatitis (NASH)
Polaris Group60 enrolled10 locationsNCT05842512
Recruiting
Phase 2
Low-Dose Pioglitazone in Patients With NASH (AIM 2)
Type 2 Diabetes Mellitus (T2DM)Nonalcoholic Steatohepatitis
University of Florida166 enrolled1 locationNCT04501406
Recruiting
Phase 2
Namodenoson in the Treatment of Non-Alcoholic Steatohepatitis (NASH)
NASH - Nonalcoholic Steatohepatitis
Can-Fite BioPharma114 enrolled24 locationsNCT04697810